Cargando…

Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hörmannsperger, Gabriele, Clavel, Thomas, Hoffmann, Micha, Reiff, Caroline, Kelly, Denise, Loh, Gunnar, Blaut, Michael, Hölzlwimmer, Gabriele, Laschinger, Melanie, Haller, Dirk
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634842/
https://www.ncbi.nlm.nih.gov/pubmed/19197385
http://dx.doi.org/10.1371/journal.pone.0004365
_version_ 1782164165069111296
author Hörmannsperger, Gabriele
Clavel, Thomas
Hoffmann, Micha
Reiff, Caroline
Kelly, Denise
Loh, Gunnar
Blaut, Michael
Hölzlwimmer, Gabriele
Laschinger, Melanie
Haller, Dirk
author_facet Hörmannsperger, Gabriele
Clavel, Thomas
Hoffmann, Micha
Reiff, Caroline
Kelly, Denise
Loh, Gunnar
Blaut, Michael
Hölzlwimmer, Gabriele
Laschinger, Melanie
Haller, Dirk
author_sort Hörmannsperger, Gabriele
collection PubMed
description BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(ΔARE) and IL-10(−/−) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(−/−) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.
format Text
id pubmed-2634842
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26348422009-02-06 Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation Hörmannsperger, Gabriele Clavel, Thomas Hoffmann, Micha Reiff, Caroline Kelly, Denise Loh, Gunnar Blaut, Michael Hölzlwimmer, Gabriele Laschinger, Melanie Haller, Dirk PLoS One Research Article BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(ΔARE) and IL-10(−/−) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(−/−) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect. Public Library of Science 2009-02-06 /pmc/articles/PMC2634842/ /pubmed/19197385 http://dx.doi.org/10.1371/journal.pone.0004365 Text en Hörmannsperger et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hörmannsperger, Gabriele
Clavel, Thomas
Hoffmann, Micha
Reiff, Caroline
Kelly, Denise
Loh, Gunnar
Blaut, Michael
Hölzlwimmer, Gabriele
Laschinger, Melanie
Haller, Dirk
Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title_full Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title_fullStr Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title_full_unstemmed Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title_short Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation
title_sort post-translational inhibition of ip-10 secretion in iec by probiotic bacteria: impact on chronic inflammation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634842/
https://www.ncbi.nlm.nih.gov/pubmed/19197385
http://dx.doi.org/10.1371/journal.pone.0004365
work_keys_str_mv AT hormannspergergabriele posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT clavelthomas posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT hoffmannmicha posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT reiffcaroline posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT kellydenise posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT lohgunnar posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT blautmichael posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT holzlwimmergabriele posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT laschingermelanie posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation
AT hallerdirk posttranslationalinhibitionofip10secretioniniecbyprobioticbacteriaimpactonchronicinflammation